Nikolaos Lazarinis - Concepedia

Author

Nikolaos Lazarinis

Karolinska Institutet ORCID

Also Known As

J. Konradson, N Lazarinis, N. Lazarinis, Nikolaos Lazarinis, Nikos Lazarinis

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Karolinska Institutet Karolinska University Hospital AstraZeneca (Sweden)University of Manchester Umeå University

About

Nikolaos Lazarinis is an author at Karolinska Institutet specializing in medicine, asthma, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	376
2	Allergy	2	2	269
3	Engineering	1	1	62
4	Allergy Medicine	1	1	135
5	Biochemistry	1	1	62

Nikolaos Lazarinis

Publications

565

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of multiple doses of QGE031 (ligelizumab) versus omalizumab and placebo in inhibiting allergen-induced early asthmatic responses Gail M. Gauvreau, P. Jonathan, Louis‐Philippe Boulet, Journal of Allergy and Clinical Immunology AsthmaVersus OmalizumabAllergyMultiple DosesAllergy Medicine	2016	135
IL-17–high asthma with features of a psoriasis immunophenotype Jörgen Östling, Marleen van Geest, James Schofield, Journal of Allergy and Clinical Immunology AsthmaAllergyImmunologyIl-17–high AsthmaMedicine	2019	134
Combination of budesonide/formoterol on demand improves asthma control by reducing exercise-induced bronchoconstriction Nikolaos Lazarinis, Leif Jørgensen, Tommy Ekström, Thorax	2013	94
Urinary Leukotriene E <sub>4</sub> and Prostaglandin D <sub>2</sub> Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study Johan Kolmert, Cristina Gómez, David Balgoma, American Journal of Respiratory and Critical Care Medicine	2020	75
Correlation-Based Deconvolution (CorrDec) To Generate High-Quality MS2 Spectra from Data-Independent Acquisition in Multisample Studies I. Tada, Romanas Chaleckis, Hiroshi Tsugawa, Analytical Chemistry EngineeringMetabolomic ProfilingMultiomicsSpectrochemical AnalysisBioanalysis	2020	62
Leukotriene E4 induces airflow obstruction and mast cell activation through the cysteinyl leukotriene type 1 receptor Nikolaos Lazarinis, Johan Bood, Cristina Gómez, Journal of Allergy and Clinical Immunology AsthmaInflammationCytokineSignal TransductionInflammatory Lung Disease	2018	45
COVID-19 vaccination in the setting of mastocytosis—Pfizer-BioNTech mRNA vaccine is safe and well tolerated Nikolaos Lazarinis, Apostolos Bossios, Theo Gülen The Journal of Allergy and Clinical Immunology In Practice	2022	20

Page 1